BALCX
Price
$34.71
Change
+$0.22 (+0.64%)
Updated
Jan 17 closing price
Net Assets
240.18B
GCBUX
Price
$34.57
Change
+$0.12 (+0.35%)
Updated
Jan 17 closing price
Net Assets
398.39M
Ad is loading...

BALCX vs GCBUX

Header iconBALCX vs GCBUX Comparison
Open Charts BALCX vs GCBUXBanner chart's image
American Funds American Balanced C
Price$34.71
Change+$0.22 (+0.64%)
VolumeN/A
Net Assets240.18B
Green Century Balanced Institutional
Price$34.57
Change+$0.12 (+0.35%)
VolumeN/A
Net Assets398.39M
BALCX vs GCBUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. GCBUX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and GCBUX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 240B vs. GCBUX (398M). BALCX pays higher dividends than GCBUX: BALCX (1.59) vs GCBUX (0.83). BALCX was incepted earlier than GCBUX: BALCX (24 years) vs GCBUX (4 years). BALCX is a more actively managed with annual turnover of: 171.00 vs. GCBUX (21.00). BALCX has a lower initial minimum investment than GCBUX: BALCX (250) vs GCBUX (250000). BALCX annual gain was more profitable for investors over the last year : 11.44 vs. GCBUX (4.68).
BALCXGCBUXBALCX / GCBUX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years4 years-
Gain YTD1.9380.787246%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets240B398M60,302%
Annual Yield % from dividends1.590.83191%
Returns for 1 year11.444.68245%
Returns for 3 years10.59-1.76-603%
Returns for 5 years25.92N/A-
Returns for 10 years49.96N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVT53.560.71
+1.34%
Avnet
BKR46.540.21
+0.45%
Baker Hughes Company
VYGR5.070.01
+0.20%
Voyager Therapeutics
DEA11.520.02
+0.17%
Easterly Government Properties
SABS3.53-0.03
-0.84%
SAB Biotherapeutics